| Literature DB >> 35392213 |
Verena Liebers1, Sabine Kespohl1, Gerda Borowitzki1, Heike Stubel1, Monika Raulf1.
Abstract
Indoor mold infestation can lead to a variety of adverse health effects, including allergic and non-allergic respiratory complaints. Especially if no evidence of an allergic reaction can be found for the complaints, diagnostic tools that might explain mold-associated health problems are missing. As a proof-of-concept, in the present study whole blood assay (WBA) was used to determine cellular response by measuring cytokine release (IL-1β and IL-8) after in vitro stimulation. Blood was available from a total of 48 subjects. By questionnaire, complaints and possible mold exposure were documented. Specific in vitro blood stimulation was tested with Escherichia coli endotoxin and extracts of different molds (Aspergillus fumigatus, Penicillium chrysogenum, Aspergillus versicolor, and Cladosporium herbarum). To characterize the relevance of WBA in describing the mold-induced immune response, we compared the following groups: asthmatics vs. non-asthmatics, mx1-sensitized vs. non-mx1-sensitized, mold-exposed vs. non-mold-exposed. In response to endotoxin stimulation, a significantly higher IL-1β release was found in mx1-sensitized than in non-mx1-sensitized subjects. Furthermore, the blood of asthmatics showed significantly higher IL-8 and IL-1β release after stimulation with Penicillium chrysogenum and endotoxin, respectively, compared to non-asthmatics. However, no significant difference in the level of cytokine release was observed between the mold-exposed and non-exposed group, neither after endotoxin nor mold stimulation. In conclusion, the WBA used in this study is not a suitable tool for clinical routine diagnostic workup. Our data suggests that WBA reflects cellular differences that are disease-related but not directly attributable to mold exposure. However, in combination with further data, WBA will be a helpful und interesting tool in research, e.g., in description of the complex immune response to molds. © Dustri-Verlag Dr. K. Feistle.Entities:
Keywords: cytokine release; endotoxin; mold; mold exposure; respiratory symptoms; whole blood assay
Year: 2022 PMID: 35392213 PMCID: PMC8982069 DOI: 10.5414/ALX02299E
Source DB: PubMed Journal: Allergol Select ISSN: 2512-8957
Classification of all subjects (n = 48) based on their mold exposure.
| Whole blood assay study group (n = 48) | ||
|---|---|---|
| Mold-exposed | Non-mold exposed | |
| Male: n (%) | 16 (55) | 9 (47) |
| Age (years): median (range) | 48 (23 – 75) | 45 (22 – 60) |
| ≥ 50 years: n (%) | 13 (45) | 8 (42) |
| Smoker: n (%) | 5 (17) | 3 (16) |
| Mold-sensitized (mx1): n (%) | 10 (34) | 2 (11) |
| sx1-positive: n (%) | 18 (62) | 8 (42) |
| Respiratory symptoms: n (%) | 26 (90) | 9 (47) |
| Asthma: n (%) | 20 (69) | 4 (21) |
Figure 1.Comparison of cytokine release in whole blood assay from mold-exposed (n = 29) and non-exposed (n =19) subjects with respect to IL-1β and IL-8 release after stimulation with endotoxin or mold extracts. Median and 90% percentile are shown. *Molds were used in an estimated final concentration of 1 mg/mL based on calculation of the total extracted weight of mold (30 mg/mL).
Classification of all subjects (n = 48) based on questionnaire documented asthma diagnosis.
| Whole blood assay study group (n = 48) | ||
|---|---|---|
| With asthma | Without asthma | |
| Male: n (%) | 15 (62) | 10 (42) |
| Age (years): median (range) | 50 (23 – 75) | 44 (22 – 60) |
| ≥ 50 years: n (%) | 13 (54) | 8 (33) |
| Smoker: n (%) | 4 (17) | 4 (17) |
| Mold-sensitized (mx1): n (%) | 11 (46) | 1 (4) |
| sx1-positive: n (%) | 16 (67) | 8 (33) |
| Respiratory symptoms: n (%) | 24 (100%) | 11 (46) |
| Mold exposed: n (%) | 20 (83) | 9 (37) |
Figure 2.Comparison of cytokine release in whole blood assay of asthmatics (n = 24) and non-asthmatics (n = 24) with respect to IL-1β and IL-8 release after stimulation with endotoxin or mold extracts. Median and 90% percentile are shown. *Molds were used in an estimated final concentration of 1 mg/mL based on calculation of the total extracted weight of mold (30 mg/mL).
Classification of all subjects (n = 48) based on mold sensitization (mx1-sIgE ≥ 0.35 kUA/L).
| Whole blood assay study group (n = 48) | ||
|---|---|---|
| Mold sensitized (mx1) | Non-mold sensitized | |
| Male: n (%) | 10 (83) | 14 (39) |
| Age (years): median (range) | 52 (23 – 65) | 46 (22 – 75) |
| ≥ 50 years: n (%) | 7 (58) | 14 (39) |
| Smoker: n (%) | 2 (17) | 6 (50) |
| Respiratory symptoms: n (%) | 12 (100) | 23 (64) |
| Asthma: n (%) | 12 (100) | 13 (36) |
| Mold-exposed: n (%) | 10 (83) | 19 (53) |
| sx1-positive: n (%) | 11 (92) | 15 (42) |
Figure 3.Comparison of cytokine release in whole blood assay of mx1-positive (n = 12) and mx1-negative (n = 36) subjects with respect to IL-1β and IL-8 release after stimulation with endotoxin or mold extracts. Median and 90% percentile are shown. *Molds were used in an estimated final concentration of 1 mg/mL based on calculation of the total extracted weight of mold (30 mg/mL).